Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Pre-market
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverINBP
Consumer DefensiveOQXUSD

Integrated BioPharma, Inc.

$00123456789.00123456789001234567890.0%
52w low (est.) $0.13$0.20 52w high (est.)
Market data · updated 1h ago
Market data
Market cap
USD4.97M
52w range
USD0.14 - USD0.42
Beta
0.35
Sector
Consumer Defensive
Data quality
83/100
Valuation
DCF fair value
USD0.35
Margin of safety
+118.7%
Quality & efficiency
Moat score
10/100
Return on equity
-8.4%
Profit margin
-3.4%
Debt / equity
0.18
Growth & analysts
Revenue growth
-27.5%
Run the 10-point checklist before you buy How these numbers are made

About Integrated BioPharma, Inc.

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Valuation

ValueGrowthProfitHealthIncome41QUALITY
Overall Rating
46
Hold
Hold

Derived from filed metrics · High confidence (83% of the inputs available)

Moat Score10
DCF Intrinsic Value
USD0.35+118.7% upside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD4.97M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
-27.5%
Profit Margin
-3.4%
ROE
-8.4%
Debt / Equity
0.18
Beta
0.35
Beaten Down
vs Consumer Defensive sector:Moat 10 vs 0Yield 0.00% vs 0.0%

Statistics

Similar Stocks · Consumer Defensive

Latest News · INBP